Skip to main content

Table 1 Demographic, functional and inflammatory characteristics for the whole population

From: Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation

Characteristics

 

N.

508

Sex (M/F)

201/307

Age, yrs

52 (19–88)

Height, cm

167 ± 9

Weight, kg

74 ± 16

Atopy (Y/N)

296/212 (58%)

Current Smoker (n) (pack-yr)

101 (22 (0.5-60) pack-yr)

Ex-smokers (n) (pack-yr)

99 (15 (0.5-90) pack-yr)

FEV1,% predicted

84 ± 19

Sputum eosinophils,%

2 (0–94)

Sputum neutrophils,%

45 (0–100)

ICS therapy

 

   Steroid naïve

153 (30%)

   Low dose ICS

73 (15%)

   Moderate dose ICS

138 (27%)

   High dose ICS

144 (28%)

  1. Data are presented as mean ± SD or median (range). FEV 1 , forced expiratory volume in 1 s. ICS: inhaled corticosteroids. Low dose: ≤500 μg/day beclomethasone; Moderate dose: 500-1000 μg/day beclomethasone; High dose: >1000 μg/day beclomethasone.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us